98 related articles for article (PubMed ID: 1615490)
1. Liver blood flow as a major determinant of the clearance of recombinant human tissue-type plasminogen activator.
de Boer A; Kluft C; Kroon JM; Kasper FJ; Schoemaker HC; Pruis J; Breimer DD; Soons PA; Emeis JJ; Cohen AF
Thromb Haemost; 1992 Jan; 67(1):83-7. PubMed ID: 1615490
[TBL] [Abstract][Full Text] [Related]
2. Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activator.
van Griensven JM; Huisman LG; Stuurman T; Dooijewaard G; Kroon R; Schoemaker RC; Kluft K; Cohen AF
Clin Pharmacol Ther; 1996 Nov; 60(5):504-11. PubMed ID: 8941023
[TBL] [Abstract][Full Text] [Related]
3. Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
van Griensven JM; Koster RW; Burggraaf J; Huisman LG; Kluft C; Kroon R; Schoemaker RC; Cohen AF
Clin Pharmacol Ther; 1998 Jan; 63(1):39-47. PubMed ID: 9465840
[TBL] [Abstract][Full Text] [Related]
4. Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver.
Tanswell P; Heinzel G; Greischel A; Krause J
J Pharmacol Exp Ther; 1990 Oct; 255(1):318-24. PubMed ID: 2120422
[TBL] [Abstract][Full Text] [Related]
5. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
[TBL] [Abstract][Full Text] [Related]
6. Hepatic clearance of tissue-type plasminogen activator in rats.
Emeis JJ; van den Hoogen CM; Jense D
Thromb Haemost; 1985 Oct; 54(3):661-4. PubMed ID: 3937264
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator.
Tanswell P; Seifried E; Stang E; Krause J
Arzneimittelforschung; 1991 Dec; 41(12):1310-9. PubMed ID: 1815534
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and haemostatic status during consecutive infusions of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction.
Seifried E; Tanswell P; Ellbrück D; Haerer W; Schmidt A
Thromb Haemost; 1989 Jun; 61(3):497-501. PubMed ID: 2508258
[TBL] [Abstract][Full Text] [Related]
9. Clearance of t-PA, PAI-1, and t-PA-PAI-1 complex in an isolated perfused rat liver system.
Wing LR; Hawksworth GM; Bennett B; Booth NA
J Lab Clin Med; 1991 Feb; 117(2):109-14. PubMed ID: 1899689
[TBL] [Abstract][Full Text] [Related]
10. The influence of carbohydrate structure on the clearance of recombinant tissue-type plasminogen activator.
Hotchkiss A; Refino CJ; Leonard CK; O'Connor JV; Crowley C; McCabe J; Tate K; Nakamura G; Powers D; Levinson A
Thromb Haemost; 1988 Oct; 60(2):255-61. PubMed ID: 2851193
[TBL] [Abstract][Full Text] [Related]
11. Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects.
De Boer A; Kluft C; Kasper FJ; Kroon JM; Schoemaker HC; Breimer DD; Soons PA; Cohen AF
Br J Clin Pharmacol; 1993 Aug; 36(2):99-104. PubMed ID: 8398589
[TBL] [Abstract][Full Text] [Related]
12. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
[TBL] [Abstract][Full Text] [Related]
13. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
[TBL] [Abstract][Full Text] [Related]
14. Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein.
Cugno M; Cicardi M; Colucci M; Bisiani G; Merlini PA; Spinola A; Paonessa R; Agostoni A
Thromb Haemost; 1996 Aug; 76(2):234-8. PubMed ID: 8865537
[TBL] [Abstract][Full Text] [Related]
15. Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.
Soons PA; De Boer A; Cohen AF; Breimer DD
Br J Clin Pharmacol; 1991 Dec; 32(6):697-704. PubMed ID: 1768562
[TBL] [Abstract][Full Text] [Related]
16. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
Collen D; Stassen JM; De Cock F
Thromb Haemost; 1987 Oct; 58(3):943-6. PubMed ID: 3124288
[TBL] [Abstract][Full Text] [Related]
18. The effect of submaximal exercise on fibrinolysis.
Fras Z; Keber D; Chandler WL
Blood Coagul Fibrinolysis; 2004 Apr; 15(3):227-34. PubMed ID: 15060418
[TBL] [Abstract][Full Text] [Related]
19. Total body and hepatic clearance in rats of recombinant tissue-type plasminogen activator expressed in mouse C127 and Chinese hamster ovary cells.
Hori R; He YL; Shima T; Inui K; Aoki S; Okumura K; Tanigawara Y
Drug Metab Dispos; 1992; 20(4):541-6. PubMed ID: 1356732
[TBL] [Abstract][Full Text] [Related]
20. Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activator.
Okada K; Lijnen HR; Moreau H; Vanderschueren S; Collen D
Thromb Haemost; 1996 Dec; 76(6):857-9. PubMed ID: 8972000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
